SCHEMBL371618

SCHEMBL371618

CC/C=C\CCCCCCCC(=O)O

nearest known ligand 0.89

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.89
F7 P08709 6/20 0.89
F3 P13726 6/20 0.89
PPARG P37231 6/20 0.89
PPARD Q03181 6/20 0.89
PPARA Q07869 6/20 0.89
CYP19A1 P11511 5/20 0.89
MAPT P10636 4/20 0.89
HSD17B10 Q99714 4/20 0.89
PTGS1 P23219 4/20 0.89
BLM P54132 3/20 0.89
KMT2A Q03164 3/20 0.89
LMNA P02545 3/20 0.89
ALOX15 P16050 3/20 0.89
TDP1 Q9NUW8 3/20 0.89
RECQL P46063 2/20 0.89
OXER1 Q8TDS5 2/20 0.89
KDM4E B2RXH2 2/20 0.89
FFAR1 O14842 2/20 0.89
CYP3A4 P08684 2/20 0.89

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8020062 1.00 ALDH1A1 (0.89) ALDH1A1F7F3PPARGPPARD
SCHEMBL2941427 1.00 ALDH1A1 (0.89) ALDH1A1F7F3PPARGPPARD
SCHEMBL2318370 1.00 ALDH1A1 (0.89) ALDH1A1F7F3PPARGPPARD
SCHEMBL1655437 1.00 ALDH1A1 (0.89) ALDH1A1F7F3PPARGPPARD
SCHEMBL2574583 1.00 ALDH1A1 (0.89) ALDH1A1F7F3PPARGPPARD
SCHEMBL8005040 1.00 ALDH1A1 (0.89) ALDH1A1F7F3PPARGPPARD
SCHEMBL25326380 1.00 ALDH1A1 (0.89) ALDH1A1F7F3PPARGPPARD
SCHEMBL4333112 1.00 ALDH1A1 (0.89) ALDH1A1F7F3PPARGPPARD
SCHEMBL7635697 1.00 ALDH1A1 (0.89) ALDH1A1F7F3PPARGPPARD
SCHEMBL10715420 1.00 ALDH1A1 (0.89) ALDH1A1F7F3PPARGPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 155 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4658793-A1 A PROCESS FOR PRODUCING PHEROMONES AND APPLICATIONS THEREOF ATGC Biotech Pvt Ltd (IN) 2025-12-10 EP claimed
WO-2025090914-A9 CARBOXYLIC ACID REDUCTASE VARIANTS AND METHODS OF USE GENOMATICA, INC. (US) 2025-07-17 WO claimed
WO-2025090952-A1 DESATURASE VARIANTS AND METHODS OF USE GENOMATICA, INC. (US) 2025-05-01 WO claimed
WO-2025090914-A1 CARBOXYLIC ACID REDUCTASE VARIANTS AND METHODS OF USE GENOMATICA, INC. (US) 2025-05-01 WO claimed
WO-2024161427-A1 A PROCESS FOR PRODUCING PHEROMONES AND APPLICATIONS THEREOF ATGC BIOTECH PVT LTD (IN) 2024-08-08 WO claimed
EP-3377465-B1 PRODUCTION OF FATTY OLEFIN DERIVATIVES VIA OLEFIN METATHESIS PROVIVI INC (US) 2023-08-02 EP claimed
US-11420926-B2 Methods of making olefinic E- and Z-isomers VERBIO VEREINIGTE BIOENERGIE AG (DE) 2022-08-23 US claimed
US-20210122697-A1 METHODS OF MAKING OLEFINIC E- AND Z-ISOMERS VERBIO SE (DE) 2021-04-29 US claimed
EP-3630741-A1 METHODS OF MAKING OLEFINIC E- AND Z-ISOMERS Verbio Vereinigte Bioenergie AG (DE) 2020-04-08 EP claimed
CN-109890832-A Half biology of fatty alcohol and fatty aldehyde is synthetically produced 普罗维维股份有限公司 2019-06-14 CN claimed
EP-2970633-A1 STABILIZED POLYMER COMPOSITIONS AND METHODS OF MAKING SAME Baerlocher GmbH (DE) 2016-01-20 EP claimed
EP-2840112-A1 Stabilized polymer compositions and methods of making same Baerlocher GmbH (DE) 2015-02-25 EP claimed
WO-2014140383-A1 STABILIZED POLYMER COMPOSITIONS AND METHODS OF MAKING SAME BAERLOCHER GMBH (DE) 2014-09-18 WO claimed
US-7997342-B2 Subterranean treatment fluids comprising viscoelastic surfactant gels HALLIBURTON ENERGY SERVICES, INC. (US) 2011-08-16 US claimed
US-7939471-B2 Comprising an aqueous base fluid, a non-aqueous tackifying agent, and a viscoelastic surfactant; enhanced rheological properties as compared to viscoelastic surfactant fluids or gels known in the art, especially at higher temperatures HALLIBURTON ENERGY SERVICES, INC. (US) 2011-05-10 US claimed
US-20090305913-A1 DUAL-FUNCTION ADDITIVES FOR ENHANCING FLUID LOSS CONTROL AND STABILIZING VISCOELASTIC SURFACTANT FLUIDS HALLIBURTON ENERGY SERVICES, INC. 2009-12-10 US claimed
EP-2094809-A2 DUAL-FUNCTION ADDITIVES FOR ENHANCING FLUID LOSS CONTROL AND STABILIZING VISCOELASTIC SURFACTANT FLUIDS Halliburton Energy Services, Inc. (US) 2009-09-02 EP claimed
WO-2008081158-A2 DUAL-FUNCTION ADDITIVES FOR ENHANCING FLUID LOSS CONTROL AND STABILIZING VISCOELASTIC SURFACTANT FLUIDS HALLIBURTON ENERGY SERVICES, INC. (US) 2008-07-10 WO claimed
US-20080161210-A1 Subterranean treatment fluids comprising viscoelastic surfactant gels HALLIBURTON ENERGY SERVICES, INC. 2008-07-03 US claimed
US-20080161212-A1 Dual-function additives for enhancing fluid loss control and stabilizing viscoelastic surfactant fluids HALLIBURTON ENERGY SERVICES, INC. 2008-07-03 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11420926-B2 Methods of making olefinic E- and Z-isomers SQLE, OXER1, POR ALDH1A1 325/4885F7 528/4885F3 1126/4885
US-20210122697-A1 METHODS OF MAKING OLEFINIC E- AND Z-ISOMERS SQLE, OXER1, POR ALDH1A1 325/4885F7 528/4885F3 1126/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.